Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA greenlights first non-opioid treatment for severe pain in 20 years
Journavax was shown in clinical trials to be safe and effective, with no addictive potential.
PCI before TAVR linked to better outcomes than performing both at once
Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.
Swedish total artificial heart tech granted FDA’s humanitarian use designation
Realheart celebrated the news, noting that multiple preclinical trials focused on the technology's safety and effectiveness are currently underway.
New findings prompt experts to call for routine brain imaging of certain breast cancer patients
New research suggests more women with late-stage breast cancer may develop brain metastases than previously believed.
Medical device company raises $36M for emitter-free IVL platform
Boston-based Amplitude Vascular Systems is busy investigating the performance of its Pulse IVL platform in a wide variety of patient populations.

Ischemic stroke CT scan showing color coded blood flow for early and later arterial and venous contrast phases and areas of blocked blood flow. Image courtesy of RSNA

Disparities evident as CT stroke imaging rises sharply over 7-year period

Utilization of head CT perfusion (CTP) for imaging stroke patients spiked 428% between 2012 and 2019. Curiously, the uptrend was associated with higher mortality up to a year after discharge.

Long COVID-19 impacts 30% of infected patients

Fatigue and shortness of breath are among the most common symptoms reported by patients.

Machinist Patrick Leibich of Penn State College of Medicine’s division of Applied Biomedical Engineering works to create artificial heart parts. Image courtesy of Penn State.

Penn State researchers receive more than $3 million to develop new-look artificial heart

The group will be working to develop a wireless artificial heart that can last at least 10 years.

Nurses on the frontlines face ‘moral distress’

Nurses who have been on the frontlines of the COVID-19 pandemic since the early days in 2020 have all experienced “moral distress,” according to a recent study.

FDA announces another recall of common hypertension medication due to potential cancer risk

The new recall includes five lots of medications distributed from December 2019 to April 2022. Similar products were also recalled back in March for the same reason.

Biden-Trump presidential election linked to a higher heart attack risk among white, male and older individuals

“There is a need for awareness of this higher risk of CVD, and further research is warranted to identify strategies that mitigate cardiovascular risk during notable political events,” researchers explained.

New York cardiologist charged for alleged involvement in COVID-related fraud scheme

He was charged with three counts of healthcare fraud for an alleged scheme involving office visits that never occurred.

4 support catheters receive FDA clearance for coronary use

The catheters were developed to be used during percutaneous coronary intervention procedures for coronary artery disease.

Clinical

FDA greenlights first non-opioid treatment for severe pain in 20 years

PCI before TAVR linked to better outcomes than performing both at once

Swedish total artificial heart tech granted FDA’s humanitarian use designation

New findings prompt experts to call for routine brain imaging of certain breast cancer patients

Medical device company raises $36M for emitter-free IVL platform